Study M993
Study name | Romero-Sanchiz P 2019 |
Title | Plasma concentrations of oleoylethanolamide in a primary care sample of depressed patients are increased in those treated with selective serotonin reuptake inhibitor-type antidepressants |
Overall design | The aim of this study was to compare the plasma concentrations of oleoylethanolamide and related acylethanolamides in a sample of primary care patients with depression (depression group, n = 69) with those of healthy non-depressed patients (control group, n = 47). Plasma levels of acylethanolamides and monoacylglycerols were detected using liquid chromatography-coupled tandem mass spectrometry system. |
Study Type | Type1; |
Data available | Unavailable |
Organism | Human; |
Categories of depression | Depressive disorder; Depression; Depression; |
Criteria for depression | DSM-IV diagnosed MDD |
Sample size | 116 |
Tissue | Peripheral; Blood; Plasma; |
Platform | MS-based; LC-MS: liquid chromatography with Agilent 6410 triple quadrupole (Agilent Technologies, Wilmington, DE, USA); |
PMID | |
DOI | |
Citation | Romero-Sanchiz P, Nogueira-Arjona R, Pastor A, et al. Plasma concentrations of oleoylethanolamide in a primary care sample of depressed patients are increased in those treated with selective serotonin reuptake inhibitor-type antidepressants. Neuropharmacology. 2019 May 1;149:212-220. |
Metabolite | MG(0:0/20:4(5Z,8Z,11Z,14Z)/0:0); Anandamide; Oleoylethanolamide; Docosahexaenoyl Ethanolamide; Linoleoyl ethanolamide; |
